Current position:Home >Product >
4-({3-[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]phenyl}sulfonyl)morpholine
4-({3-[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]phenyl}sulfonyl)morpholine(5919-81-3)
- Name: 4-({3-[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]phenyl}sulfonyl)morpholine
- Synonyms:
- Molecular Formula:C18H16BrN3O4S
- Molecular Weight:450.3063
- CAS Registry Number:5919-81-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 17722-71-3/N-(3,4-DICHLORO-PHENYL)-SUCCINAMIC ACID
- 99506-24-8/N-[1-cyclohexylidene-2-(4-methylpiperazin-1-yl)-2-oxoethyl]formamide
- 150525-63-6/2-(2,4-difluorophenyl)-3-[4-(pyridin-3-yl)phenyl]-1-(1H-1,2,4-triazol-1-yl)but-3-en-2-ol methanesulfonate (1:2)
- 5451-75-2/octadecyl formate
- 51-13-8/behenyltrimethylammonium methosulfate
- 76822-23-6/Homoibotenic acid
- 6963-61-7/2,6-dioxo-2,5,6,9-tetrahydro-1H-purine-8-diazonium
- 109-98-8/2-PYRAZOLINE
- 6706-67-8/6-chloro-3-(4-chlorobenzyl)-5,7-dimethyl-3,4-dihydro-2H-1,3-benzoxazin-3-ium
- 6621-70-1/4-Methoxy-2,4,6-cycloheptatrien-1-one
- 134619-64-0/L-Ascorbic acid,esters,6-hexadecanoate,mixt. with (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2- [(4R,8R)-4,8,12-trimethyltridecyl]-2H-1- benzopyran-6-ol
- 1501-26-4/Methyl 4-(chloroformyl)butyrate
- 5325-95-1/2-cyanoethyl benzoate
- 170752-94-0/30-Noroleana-12,20(29)-dien-28-oicacid, 3-[(O-b-D-glucopyranosyl-(1®3)-O-[b-D-xylopyranosyl-(1®2)]-a-L-arabinopyranosyl)oxy]-23-hydroxy-, (3b,4a)- (9CI)
- 13972-33-3/2-{4-[2-(4-chlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]phenoxy}-N-ethylethanaminium chloride
- 32251-76-6/1-methyl-5,5-diphenyl-4,5-dihydro-1H-pyrazole
- 51707-12-1/(8E,24E)-8-({2-[(4-bromophenyl)carbonyl]hydrazino}methylidene)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
- 153146-42-0/b-D-Glucopyranoside,(1R)-1-ethenyl-1,5-dimethyl-4-hexenyl2-O-[6-deoxy-4-O-[(2E,6R)-6-[[2-O-[(2E,6R)-6-(b-D-glucopyranosyloxy)-2,6-dimethyl-1-oxo-2,7-octadienyl]-b-D-glucopyranosyl]oxy]-2,6-dimethyl-1-oxo-2,7-octadienyl]-a-L-mannopyranosyl]- (9CI)
- 5919-81-3/4-({3-[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]phenyl}sulfonyl)morpholine
- 1126-51-8/4-Carbethoxybutyrolactone,γ-Carboethoxy-γ-butyrolactone
- 83733-23-7/Disodium (3-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulphonato(3-))(2-((2-hydroxybenzylidene)amino)-4-nitrophenolato(2-)-N2,O1,O2)chromate(2-)
- 158640-34-7/Cuprate(4-),[2-[2-[[4-[(2-chloroethyl)sulfonyl]phenyl][2-[2-(hydroxy-kO)-5-sulfo-3-[[[[2-[[2-(sulfooxy)ethyl]sulfonyl]ethyl]amino]carbonyl]amino]phenyl]diazenyl-kN2]methyl]diazenyl-kN1]-4-sulfobenzoato(6-)-kO]-, sodium (1:4)
- 2234-75-5/1,2,4-TRIMETHYLCYCLOHEXANE
- 66787-06-2/2-[({[(2,6-dimethylphenoxy)carbothioyl]disulfanyl}carbothioyl)oxy]-1,3-dimethylbenzene
- 84961-41-1/Amines, C10-14-branched and linear alkyl, bis(3-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-2-hydroxy-5-nitrobenzenesulfonato(3-))chromate(3-), sodium salts
- 90632-39-6/Carapolide E
- 134705-50-3/1,4,6,9-tetrachlorodibenzo[b,d]thiophene
- 140367-81-3/7,11:18,22-Dimethano-4H,6H-dipyrido[1,2-a:1',2'-i][1,5,9,13]tetraazacyclohexadecine-9,20(10H,19H)-dicarboxaldehyde,7,8,11,15,17,18,21,22-octahydro-4,15-dioxo-, (7R,11R,18S,22S)-rel-(+)- (9CI)
- 6029-19-2/4-(5-benzyl-2,6-dimethylpyrimidin-4-yl)-N-(3,4-difluorophenyl)piperazine-1-carboxamide
- 80568-61-2/1-{[2-(diethylamino)ethyl]amino}-4-hydroxy-9H-thioxanthen-9-one